CAMBRIDGE, MA, March 10, 2026 (EZ Newswire) -- R3 Bio announced the release of its 2026 research report outlining early-stage progress in developing integrated, stem cell-derived biological platforms ...

The entry of cloud technology in the software world has fundamentally changed how software is built, deployed, and scaled. Traditionally, applications were released only once or twice a year. Today, ...

R3 Bio announced the release of its 2026 research report outlining early-stage progress in developing integrated, stem cell-derived biological ...

Gig Harbor is testing the waters on breaking off from Pierce County, with one resident leading a formal effort to see whether ...

Modernise your design strategy with mobile-first and keyboard-centric approaches that create more resilient, accessible, and user-friendly software.

Scientists in Japan have developed a new analytical method capable of detecting subtle stereochemical differences that arise when therapeutic antibodies undergo oxidation. These differences, which ...

Dyne Therapeutics maintains a strong $1.1B cash position, funding operations into mid-2028 despite heavy R&D and operating ...

Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...

HARMONIA trial will assess multi-system efficacy, safety and tolerability of z-basivarsen in DM1 -- 48-week trial will enroll approximately 150 ...

Dyne Therapeutics has initiated the Phase III HARMONIA trial to evaluate the efficacy, safety, and tolerability of zeleciment basivarsen (z-basivarsen, also called DYNE-101) in individuals diagnosed ...

The FDA assigned a PDUFA target action date of December 22, 2026 –– The NDA is based on positive data from a successful clinical program ...

Happy Tuesday! Pronto's founder Anjali Sardana is slugging it out in the competitive instant house-help segment. This and more in today's ETtech Morning Dispatch.